Detroit Teacher Sick-Outs Continue — Check The Updated CLOSINGS LIST • FULL STORY  
Esperion Starts Next Phase Of Cholesterol Drug TrialThe Plymouth pharma startup Esperion Therapeutics Inc. (Nasdaq: ESPR), Wednesday announced the first patient in a Phase 2b clinical study had received the first dose of ETC-1002, its lead anti-cholesterol drug.

More From CBS Detroit

Daily J
Valenti and Foster

Watch & Listen